|
Volumn 295, Issue 2, 2000, Pages 621-626
|
Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing human hearts
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BRADYKININ;
DIPEPTIDYL CARBOXYPEPTIDASE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
MEMBRANE METALLOENDOPEPTIDASE;
OMAPATRILAT;
RAMIPRILAT;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG EFFECT;
ENZYME ACTIVITY;
ENZYME INHIBITION;
FEMALE;
HALF LIFE TIME;
HEART DILATATION;
HEART MUSCLE FIBER MEMBRANE;
HEART PROTECTION;
HUMAN;
HUMAN TISSUE;
ISCHEMIC HEART DISEASE;
MALE;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN METABOLISM;
TISSUE DISTRIBUTION;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
BRADYKININ;
CARDIOMYOPATHY, CONGESTIVE;
CARDIOVASCULAR AGENTS;
COMPARATIVE STUDY;
FEMALE;
HALF-LIFE;
HEART;
HUMAN;
MALE;
MEMBRANES;
MIDDLE AGE;
MYOCARDIAL ISCHEMIA;
MYOCARDIUM;
NEPRILYSIN;
PEPTIDYL-DIPEPTIDASE A;
PROTEASE INHIBITORS;
PYRIDINES;
RAMIPRIL;
SUPPORT, NON-U.S. GOV'T;
THIAZEPINES;
|
EID: 0033779470
PISSN: 00223565
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (41)
|
References (30)
|